GlaxoSmithKline immunotherapy approved by the European Union for the treatment of endometrial cancer
穿越夜时空簿
发表于 2023-12-11 17:16:26
1372
0
0
GlaxoSmithKline announced on December 11th that the European Commission has approved the use of Dostarlimab (Jemperli) in combination with carboplatin and paclitaxel for the treatment of primary advanced or recurrent endometrial cancer carrying mismatch repair defects (dMMR) or high microsatellite instability (MSI-H).
CandyLake.com is an information publishing platform and only provides information storage space services.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
转播
You may like
- 科学技術大手が連名でEUに書簡、EU規制の門をたたくことができるか
- Xiaopeng Motors responds again to 'private negotiations with EU': no private contact or negotiation with EU
- 小鵬自動車が再び「EUとの内密交渉」に応じたこと：EUとの内密接触交渉はない
- Xie Lijuan, General Manager of Sanofi Pharmaceuticals China: "Jinbo Baby" creates a "miracle" and continues to build immune leadership
- EU Ambassador to the United States: If Trump escalates trade frictions again, the EU is ready to respond
- EU駐米大使：トランプ氏が貿易摩擦を再燃すればEUは対応の用意ができている
- The EU regulatory agencies are coming down! Google and Meta's secret advertising deal investigated
- EU規制当局が退場！グーグルとメッタの秘密広告取引が発覚
- Google restores hotel search function in three EU countries
- グーグル、EU 3カ国のホテル検索機能を復活
